SAB Biotherapeutics Inc.

NASDAQ: SABS · Real-Time Price · USD
2.19
-0.02 (-0.90%)
At close: Aug 15, 2025, 3:59 PM
2.21
0.91%
After-hours: Aug 15, 2025, 07:52 PM EDT

SAB Biotherapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.03 -0.9 -1.37 -19.8
PEG Ratio
0.02 -0.01 -0.15 0.11
PS Ratio
26.55 16.96 1.07 5.58
PB Ratio
1.35 0.66 0.83 8.81
P/FCF Ratio
-1.01 -1.5 -3.57 -47.25
P/OCF Ratio
-1.02 -1.51 6.83 90.33
OCF/S Ratio
-25.94 -11.22 0.16 0.06
Debt / Equity Ratio
0.18 0.10 0.19 0.22
Quick Ratio
2.98 5.45 1.47 2.03
Current Ratio
2.98 5.45 1.47 2.03
Asset Turnover
0.03 0.03 0.47 0.77
Interest Coverage
-134.77 -120.76 -95.89 -45.48
Return on Equity
-1.31 -0.74 -0.6 -0.44
Return on Assets
-0.77 -0.5 -0.37 -0.22
Return on Invested Capital
-1.16 -0.51 -0.78 -0.22
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
-2.62 -0.67 0.86 0.97
Net Profit Margin
-25.8 -18.85 -0.78 -0.28
Pretax Profit Margin
-25.8 -18.85 -0.78 -0.28
Operating Profit Margin
-32.46 -17.01 -1.21 -0.22
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-21.93 -17.03 -0.63 -0.25